Clinical Report: Consensus Group Advocates Shift in GA Care

Overview

A consensus group of retina experts has called for a significant shift in the management of geographic atrophy (GA), emphasizing the need for multimodal imaging and earlier specialist referrals. The group identified key challenges in the current understanding and treatment of GA, advocating for improved definitions, functional outcome measures, and patient stratification.

Background

Geographic atrophy (GA) is a progressive retinal disease that significantly impacts patients' quality of life and visual function. Current diagnostic and management strategies are inadequate, often failing to capture the disease's heterogeneity and delaying necessary interventions. The recent 'Reframe GA' initiative highlights the urgency for a more comprehensive approach to GA care.

Data Highlights

No numerical data provided in the source material.

Key Findings

• The current definitions and classifications of GA are insufficient and lack consensus.
• Multimodal imaging techniques, such as OCT and fundus autofluorescence, are necessary for better phenotyping of GA.
• Best-corrected visual acuity (BCVA) is not an adequate primary endpoint for assessing GA progression.
• Early referral of patients with intermediate AMD to specialists is crucial for timely intervention.
• Patient stratification is essential to identify those at higher risk of rapid progression.

Clinical Implications

Clinicians should adopt multimodal imaging techniques to enhance the diagnosis and management of GA. Early referral to retina specialists for patients with intermediate AMD can facilitate timely interventions, potentially preserving vision and improving quality of life.

Conclusion

The 'Reframe GA' initiative advocates for a paradigm shift in GA care, emphasizing the need for improved definitions, earlier referrals, and a focus on patient-centered outcomes. This approach aims to enhance the overall management of GA and address its broader impact on patients.

References

1. Euretina Congress, 2025 -- Reframe GA White Paper
2. Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE - PubMed
3. The New Gastroenterologist — AGA Advocacy Agenda Influenced by Member Priorities
4. the asco post — Patient Advocacy Groups: Health-Care Programs Are Lifelines—Not Line Items
5. The New Gastroenterologist — AGA Advocates, Including Patients and Physicians, Lobby for Reform of Prior Authorization on Capitol Hill
6. The ASCO Post — ASCO Calls for Major Medicaid Reform to Improve Quality Cancer Care for Low-Income Americans
7. AGA Advocacy Agenda Influenced by Member Priorities
8. Patient Advocacy Groups: Health-Care Programs Are Lifelines—Not Line Items
9. AGA Advocates, Including Patients and Physicians, Lobby for Reform of Prior Authorization on Capitol Hill
10. Homepage
11. Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE - PubMed
12. New ReST Committee Report Published in JVRD Summarizes Analysis of Reported Cases of Retinal Vasculitis Following Syfovre Injection - The American Society of Retina Specialists